Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD

Bone Marrow Transplantation

Volumn 46, Issue 9, 2011, Pages 1274-1275

  Hilgendorf, I ^a   Loebermann, M ^a   Borchert, K ^a   Junghanss, C ^a   Freund, M ^a   Schmitt, M ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; AZATHIOPRINE; CYCLOSPORIN A; CYTARABINE; ENTECAVIR; EVEROLIMUS; FLUDARABINE; HEPATITIS B SURFACE ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; RAPAMYCIN; TENOFOVIR DISOPROXIL; TREOSULFAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; DNA REPLICATION; DRUG EFFICACY; FATIGUE; FEMALE; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER FUNCTION TEST; NONHUMAN; PRIORITY JOURNAL; SCLERODERMA; SJOEGREN SYNDROME; VIRUS REACTIVATION;

ADENINE; ADULT; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS ACTIVATION;

EID: 80052497806     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.290     Document Type: Article

References (10)

1. Hammond S, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 1049-1059.
2. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ, Risk Evaluation of Viral Load Elevation Associated Liver Disease/Cancer in HBV (the REVEAL-HBV) Study Group. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-686. (Pubitemid 43374518)
3. Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol 2010; 53: 348-356.
4. Zaia J, Baden L, Boeckh MJ, Chakrabarti S, Einsele H, Ljungman P et al. Viral disease prevention after hematopoietic cell transplantation. Bone Marrow Transplant 2009; 44: 471-482.
5. Seth P, Alrajhi AA, Kagevi I, Chaudhary MA, Colcol E, Sahovic E et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graftversus-host disease. Bone Marrow Transplant 2002; 30: 189-194. (Pubitemid 34993859)
6. Knöll A, Boehm S, Hahn J, Holler E, Jilg W. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33: 925-929. (Pubitemid 38660126)
7. Strasser SI, McDonald GB. Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood 1999; 93: 1127-1136. (Pubitemid 29076126)
8. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-242.
9. Woo G, Tomlinson G, Nishikawa Y, Kowgier M, Sherman M, Wong DK et al. Tenofovir and Entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology 2010; 139: 1218-1229.
10. Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM et al. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis 2002; 40: 1331-1333. (Pubitemid 35403147)